Literature DB >> 29479185

Long-term follow-up of cardiorespiratory outcomes in children born extremely preterm: Recommendations from a Canadian consensus workshop.

Sherri Lynne Katz1,2, Thuy Mai Luu3,4,5, Anne-Monique Nuyt6,7, Thierry Lacaze8,9,10, Kristi Brae Adamo11, Ian Adatia12,13,14, Tilman Humpl15,16, Robert Peter Jankov17,18,19, Theo J Moraes20,21, Katharina Staub22, Michael K Stickland23,24, Bernard Thebaud25,26,27.   

Abstract

Bronchopulmonary dysplasia, the most common pulmonary complication of extremely preterm (EPT) birth, has longstanding multiorgan repercussions, with increasing reports of emphysema and cardiac disease in early adulthood. There are currently no clear recommendations pertaining to best practices for optimal multidisciplinary cardiorespiratory follow-up of EPT children. We report the outcomes of a 2-day consensus workshop involving a Canadian panel of 31 multidisciplinary experts with the goal of improvement and standardization of the cardiopulmonary follow-up care of EPT infants (i.e., born at <28 weeks' gestation), from neonatal discharge to mid childhood. The most relevant and important clinical outcomes to evaluate were identified. Practical aspects of integrating cardiopulmonary follow-up into ambulatory care clinics were explored. This article summarizes the discussions from this workshop and provides the panel's recommendations for clinical follow-up and research priorities.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Echocardiography; Exercise; Prematurity; Respiratory function tests.

Year:  2017        PMID: 29479185      PMCID: PMC5804930          DOI: 10.1093/pch/pxx028

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  30 in total

1.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors:  R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

Review 3.  Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis.

Authors:  Ioannis A Bliziotis; Antonis Destounis; George S Stergiou
Journal:  J Hypertens       Date:  2012-07       Impact factor: 4.844

4.  Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth.

Authors:  S Parat; G Moriette; M F Delaperche; P Escourrou; A Denjean; C Gaultier
Journal:  Pediatr Pulmonol       Date:  1995-11

5.  Preterm heart in adult life: cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function.

Authors:  Adam J Lewandowski; Daniel Augustine; Pablo Lamata; Esther F Davis; Merzaka Lazdam; Jane Francis; Kenny McCormick; Andrew R Wilkinson; Atul Singhal; Alan Lucas; Nic P Smith; Stefan Neubauer; Paul Leeson
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

6.  Consensus statement for inert gas washout measurement using multiple- and single- breath tests.

Authors:  Paul D Robinson; Philipp Latzin; Sylvia Verbanck; Graham L Hall; Alexander Horsley; Monika Gappa; Cindy Thamrin; Hubertus G M Arets; Paul Aurora; Susanne I Fuchs; Gregory G King; Sooky Lum; Kenneth Macleod; Manuel Paiva; Jane J Pillow; Sarath Ranganathan; Sarah Ranganathan; Felix Ratjen; Florian Singer; Samatha Sonnappa; Janet Stocks; Padmaja Subbarao; Bruce R Thompson; Per M Gustafsson
Journal:  Eur Respir J       Date:  2013-02-08       Impact factor: 16.671

7.  The EPICure study: maximal exercise and physical activity in school children born extremely preterm.

Authors:  Liam Welsh; Jane Kirkby; Sooky Lum; Dolf Odendaal; Neil Marlow; Graham Derrick; Janet Stocks
Journal:  Thorax       Date:  2009-12-08       Impact factor: 9.139

8.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

9.  Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term.

Authors:  Elianne J L E Vrijlandt; Jorien M Kerstjens; Eric J Duiverman; Arend F Bos; Sijmen A Reijneveld
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

10.  Development of left ventricular longitudinal speckle tracking echocardiography in very low birth weight infants with and without bronchopulmonary dysplasia during the neonatal period.

Authors:  Christoph Czernik; Stefanie Rhode; Sven Helfer; Gerd Schmalisch; Christoph Bührer; Lothar Schmitz
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

View more
  3 in total

1.  Time trends and sociodemographic determinants of preterm births in pregnancy cohorts in Matlab, Bangladesh, 1990-2014.

Authors:  Anisur Rahman; Monjur Rahman; Jesmin Pervin; Abdur Razzaque; Shaki Aktar; Jamal Uddin Ahmed; Katarina Ekholm Selling; Pernilla Svefors; Shams El Arifeen; Lars Åke Persson
Journal:  BMJ Glob Health       Date:  2019-08-02

2.  Upregulating carnitine palmitoyltransferase 1 attenuates hyperoxia-induced endothelial cell dysfunction and persistent lung injury.

Authors:  Jason L Chang; Jiannan Gong; Salu Rizal; Abigail L Peterson; Julia Chang; Chenrui Yao; Phyllis A Dennery; Hongwei Yao
Journal:  Respir Res       Date:  2022-08-13

Review 3.  Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia.

Authors:  Laura Moschino; Luca Bonadies; Eugenio Baraldi
Journal:  Pediatr Pulmonol       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.